Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Patients | 2 |
Schizophrenia | 2 |
Adolescents | 1 |
Brain | 1 |
Children | 1 |
Clinical Diagnosis | 1 |
Cognitive Ability | 1 |
Cognitive Processes | 1 |
Cognitive Tests | 1 |
Developmental Stages | 1 |
Diagnostic Tests | 1 |
More ▼ |
Author
Findling, Robert L. | 1 |
Frazier, Jean A. | 1 |
Gerbino-Rosen, Ginny | 1 |
Heinrichs, R. Walter | 1 |
Kranzler, Harvey N. | 1 |
Kratochvil, Christopher J. | 1 |
Kumra, Sanjiv | 1 |
Publication Type
Journal Articles | 2 |
Opinion Papers | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Findling, Robert L.; Frazier, Jean A.; Gerbino-Rosen, Ginny; Kranzler, Harvey N.; Kumra, Sanjiv; Kratochvil, Christopher J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
This article presents responses to the question of whether clozapine is ever appropriate to use in the pediatric population. Among others, Jean A. Frazier also agreed that clozapine is appropriate for use in the pediatric population. Clozapine has truly revolutionized the treatment of refractory patients with schizophrenia at any age. This agent…
Descriptors: Patients, Adolescents, Schizophrenia, Pediatrics
Heinrichs, R. Walter – American Psychologist, 2006
In this article, I respond to comments made by K. Salzinger and A. Aleman and A. S. David on my original article. The constructive, reconstructive, and interpretive nature of human cognition is well illustrated by these two responses to my recent article on schizophrenia. In the original article, I used meta-analytic summaries of the published…
Descriptors: Patients, Schizophrenia, Cognitive Ability, Cognitive Processes